13th Aug 2024 10:16
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for GBP686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for GBP202,500. Proceeds for the disposals total GBP888,500. Both transactions took place on the London Stock Exchange. Read More
